Duopharma Biotech Berhad (KLSE:DPHARMA)
Malaysia
· Delayed Price · Currency is MYR 1.250
-0.010 (-0.79%)
At close: Dec 5, 2025
Duopharma Biotech Berhad Ratios and Metrics
Market cap in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 1,202 | 1,202 | 1,212 | 1,533 | 1,582 | 2,386 | Upgrade
|
| Market Cap Growth | 1.63% | -0.79% | -20.94% | -3.10% | -33.70% | 145.56% | Upgrade
|
| Enterprise Value | 1,428 | 1,469 | 1,522 | 1,819 | 1,881 | 2,521 | Upgrade
|
| Last Close Price | 1.25 | 1.22 | 1.20 | 1.50 | 1.55 | 2.28 | Upgrade
|
| PE Ratio | 14.39 | 19.19 | 23.02 | 21.87 | 24.09 | 40.72 | Upgrade
|
| Forward PE | 12.08 | 14.74 | 14.77 | 15.91 | 20.97 | 34.68 | Upgrade
|
| PS Ratio | 1.34 | 1.48 | 1.72 | 2.20 | 2.48 | 4.19 | Upgrade
|
| PB Ratio | 1.62 | 1.70 | 1.76 | 2.34 | 2.54 | 3.71 | Upgrade
|
| P/TBV Ratio | 1.71 | 1.71 | 1.78 | 2.35 | 2.56 | 3.73 | Upgrade
|
| P/FCF Ratio | 15.01 | 20.12 | 76.43 | 301.61 | - | 156.62 | Upgrade
|
| P/OCF Ratio | 10.82 | 14.43 | 24.84 | 21.82 | 36.62 | 33.45 | Upgrade
|
| EV/Sales Ratio | 1.58 | 1.81 | 2.16 | 2.61 | 2.94 | 4.42 | Upgrade
|
| EV/EBITDA Ratio | 8.56 | 10.70 | 13.35 | 14.80 | 16.36 | 23.80 | Upgrade
|
| EV/EBIT Ratio | 11.32 | 14.66 | 19.34 | 19.57 | 21.19 | 30.79 | Upgrade
|
| EV/FCF Ratio | 17.82 | 24.59 | 95.99 | 357.77 | - | 165.43 | Upgrade
|
| Debt / Equity Ratio | 0.66 | 0.73 | 0.80 | 0.66 | 0.65 | 0.47 | Upgrade
|
| Debt / EBITDA Ratio | 2.96 | 3.66 | 4.67 | 3.41 | 3.41 | 2.77 | Upgrade
|
| Debt / FCF Ratio | 6.16 | 8.63 | 34.61 | 84.91 | - | 19.91 | Upgrade
|
| Asset Turnover | 0.64 | 0.60 | 0.55 | 0.58 | 0.57 | 0.58 | Upgrade
|
| Inventory Turnover | 2.17 | 2.08 | 1.83 | 1.82 | 2.06 | 2.28 | Upgrade
|
| Quick Ratio | 1.62 | 2.65 | 2.59 | 1.13 | 1.18 | 1.95 | Upgrade
|
| Current Ratio | 2.54 | 4.08 | 4.06 | 2.05 | 2.15 | 3.06 | Upgrade
|
| Return on Equity (ROE) | 11.59% | 8.97% | 7.84% | 10.96% | 10.36% | 9.99% | Upgrade
|
| Return on Assets (ROA) | 5.62% | 4.60% | 3.83% | 4.87% | 4.99% | 5.17% | Upgrade
|
| Return on Capital (ROIC) | 6.40% | 5.09% | 4.24% | 5.49% | 5.62% | 5.87% | Upgrade
|
| Return on Capital Employed (ROCE) | 11.10% | 8.40% | 6.70% | 9.70% | 9.50% | 9.00% | Upgrade
|
| Earnings Yield | 6.94% | 5.21% | 4.34% | 4.57% | 4.15% | 2.46% | Upgrade
|
| FCF Yield | 6.66% | 4.97% | 1.31% | 0.33% | -4.18% | 0.64% | Upgrade
|
| Dividend Yield | 2.40% | 2.47% | 1.92% | 1.53% | 1.41% | 2.14% | Upgrade
|
| Payout Ratio | 40.32% | 42.99% | 16.81% | 11.70% | 68.45% | 12.34% | Upgrade
|
| Buyback Yield / Dilution | 0.12% | -0.36% | -1.08% | -2.15% | -0.02% | -3.86% | Upgrade
|
| Total Shareholder Return | 2.50% | 2.11% | 0.85% | -0.62% | 1.39% | -1.72% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.